AA
BMY icon

Argent Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Argent Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,930
Closed -$203K – 131
2023
Q1 		$203K Hold
2,930
– – 0.1% 127
2022
Q4 		$211K Sell
2,930
-200
-6% -$15.1K 0.11% 126
2022
Q3 		$223K Hold
3,130
– – 0.13% 118
2022
Q2 		$241K Buy
3,130
+50
+2% +$3.81K 0.14% 112
2022
Q1 		$225K Sell
3,080
-1,280
-29% -$85.9K 0.12% 133
2021
Q4 		$272K Buy
4,360
+50
+1% +$2.93K 0.15% 112
2021
Q3 		$255K Sell
4,310
-226
-5% -$14.9K 0.15% 112
2021
Q2 		$303K Buy
4,536
+663
+17% +$43.2K 0.18% 106
2021
Q1 		$245K Sell
3,873
-100
-3% -$6.22K 0.16% 115
2020
Q4 		$246K Sell
3,973
-7,217
-64% -$444K 0.15% 132
2020
Q3 		$675K Buy
11,190
+320
+3% +$19.3K 0.46% 63
2020
Q2 		$639K Buy
10,870
+1,388
+15% +$83K 0.49% 62
2020
Q1 		$529K Buy
9,482
+2,630
+38% +$161K 0.53% 53
2019
Q4 		$449K Buy
+6,852
New +$392K 0.34% 68

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Argent Advisors's BMY Position: Q2 2023 in Review

Argent Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,930 shares — an estimated $203K sold.

Argent Advisors first reported a position in BMY in Q4 2019 and held it in 14 quarters. The position peaked at $675K in Q3 2020. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Argent Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Argent Advisors sold 2,930 Bristol-Myers Squibb shares in Q2 2023, an estimated $203K.
  • Argent Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 14 quarters.
  • Argent Advisors's Bristol-Myers Squibb position peaked at $675K in Q3 2020.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Argent Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.